Effects of glucan on immunosuppressive actions of mercury

Journal of Medicinal Food

Volumn 12, Issue 5, 2009, Pages 1098-1104

  Vetvicka, Vaclav ^a   Vetvickova, Jana ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Glucan; Immune system; Immunosuppression; Mercury; Phagocytosis

Indexed keywords

DRINKING WATER; GAMMA INTERFERON; GLUCAN; INTERLEUKIN 12; INTERLEUKIN 6; MERCURY; MERCURY ACETATE; MITOGENIC AGENT; THIOMERSAL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DIET; EXPOSURE; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOTOXICITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; BETA-GLUCANS; CELL LINE; FEMALE; HUMANS; IMMUNITY; IMMUNOSUPPRESSIVE AGENTS; MERCURY; MICE; MICE, INBRED BALB C; PRESERVATIVES, PHARMACEUTICAL; THIMEROSAL;

MUS;

EID: 70350497350     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2008.0273     Document Type: Article

References (26)

1. Stratton K, Gable A, McCormic MC: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Institute of Medicine, Washington, DC, 2001.
2. Ball LK, Ball R, Pratt RD: An assessment of thimerosal use in childhood vaccines. Pediatrics 2001;107:1147-1154.
3. Ohi G, Fukuda M, Seto H, et al.: Effect of methylmercury on humoral immune responses in mice under conditions simulated to practical situations. Bull Environ Contam Toxicol 1976;15: 175-180.
4. Brown DL, Reuhl KR, Bormann S, et al.: Effects of methyl mercury on the microtubule system of mouse lymphocytes. Toxicol Appl Pharmacol 1988;94:66-75.
5. Havarinasab S, Haggqvist B, Bjorn E, et al.: Immunosuppressive and autoimmune effects of thimerosal in mice. Toxicol Appl Pharmacol 2005;204:109-121.
6. Yole M, Wickstrom M, Blakley B: Cell death and cytotoxic effects in YAC-1 lymphoma cells following exposure to various forms of mercury. Toxicology 2007;231:40-57.
7. Santarelli L, Bracii M, Mocchegiani E: In vitro and in vivo effects of mercuric chloride on thymic endocrine activity, NK and NKT cell cytotoxicity, cytokine profiles (IL-2, IFN-g, IL-6): role of the nitric oxide-l-arginine pathway. Int Immunopathol 2006; 6:376-389.
8. Cunha EM, Oliviera MJR, Ferreira PG, et al.: Mercury intake by inflammatory phagocytes in vivo cytology of mouse macrophages and neutrophils by X-ray elemental microanalysis coupled with scanning electron microscopy. Hum Exp Toxicol 2004;23:447-1353
9. Benacerraf B, Sebestyen MM: Effect of bacterial endotoxins on the reticuloendothelial system. Fed Proc 1957;16:860-867.
10. Riggi SJ, Di Luzio NR: Identification of a reticuloendothelial stimulating agent in zymosan. Am J Physiol 1961;200:297-300.
11. Di Luzio NR, Williams DL, McNamee RB, et al.: Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. Int J Cancer 1979;24:773-779.
12. Mimura H, Ohno N, Suzuki I, et al.: Purification, antitumor activity, and structural characterization of b-1,3-glucan from Peziza vesiculosa. Chem Pharm Bull 1985;33:5096-5099.
13. Patchen ML, MacVittie TJ: Use of glucan to enhance hemopoietic recovery after exposure to cobalt-60 irradiation. Adv Exp Med Biol 1982;155:267-272.
14. Vetvicka V, Dvorak B, Vetvickova J, et al.: Orally administered marine (1?3)-beta-d-glucan Phycarine stimulates both humoral and cellular immunity. Int J Biol Macromol 2006;40:291-298.
15. Vetvicka V, Fornusek L, Kopecek J, et al.: Phagocytosis of human blood leukocytes: a simple micromethod. Immunol Lett 1982;5:97-100.
16. Vetvicka V, Holub M, Kovaru H, Siman P, Kovaru F: Alphafetoprotein and phagocytosis in athymic nude mice. Immunol Lett 1988;19:95-98.
17. Magos L: Review of the toxocity of ethylmercury, including its presence as a preservative in biological and pharmaceutical products. J Appl Toxicol 2001;21:1-5.
18. Descotes J: Immunotoxicology of Drugs and Chemicals. Elsevier, Amsterdam, 1986, pp. 296-381.
19. Bernaudin JF, Druet E, Druet P, et al.: Inhalation or ingestion of organic or inorganic mercurials produces auto-immune disease in rats. Clin Immunol Immunopathol 1981;20:129-135.
20. Vetvicka V, Vetvickova J: An evaluation of the immunological activities of commercially available b-1,3-glucans. J Am Nutr Assoc 2007;10:25-31.
21. Falch BH, Espevik T, Ryan L, et al.: The cytokine stimulating activity of (1-3)-b-d-glucans is dependent on the triple helix conformation. Carbohydr Res 2000;329:587-596.
22. Bleicher P, Mackin W: Betafectin PGG-glucan: a novel carbohydrate immunomodulator with anti-infective properties. J Biotechnol Healthcare 1995;2:207-222.
23. Vetvicka V, Vashishta A, Saraswat-Ohri S, Vetvickova J: Immunological effects of yeast- and mushroom-derived b-glucans. J Med Food 2008;11:615-622.
24. Novak M, Vetvicka V: b-Glucans, history and the present: immunomodulatory aspects and mechanisms of action. J Immunotoxicol 2008;5:47-57.
25. Sarafian TA: Methylmercury-induced generation of free radicals: biological implications. Met Ions Biol Syst 1996;36:415-444.
26. Quig D: Cysteine metabolism and metal toxicity. Altern Med Rev 1998;3:262-270.